Original Coverage & Source Attribution: finance.yahoo.com
iRhythm Holdings has delivered a 59.8% share price gain over the past five years, yet its recent slide over the last year has pushed many investors to ask whether the cash flows behind the business still justify the current US$108.66 price tag. With headline news now mixing growth, legal questions and data privacy concerns, the focus naturally shifts to what the company’s cash generation can support over time.
-
The 59.8% return over 5 years puts real weight on whether that long run in iRhythm Holdings is properly backed by the cash the business can produce for shareholders.
-
Recent investigations into fiduciary duties and data privacy, alongside growth in demand for the Zio cardiac monitoring platform, may influence expectations for future profitability, legal costs and ultimately the timing and durability of cash flows.
-
Prefer to judge iRhythm Holdings on sales? See why iRhythm Holdings’s 4.3x P/S tells a different valuation story.
The issue now is whether the current share price of iRhythm Holdings is adequately supported by the cash flows implied by its Discounted Cash Flow (DCF) intrinsic value estimate.
If you are weighing iRhythm Holdings against other opportunities where valuation starts with cash generation, a focused screen of 33 high quality undervalued stocks may be useful.
Is iRhythm Holdings Still Cheap on Cash Flow?
The Discounted Cash Flow (DCF) model here leans entirely on what iRhythm Holdings can produce in free cash over time. Latest twelve month Free Cash Flow sits at about $35.6 million, while the projections used in the model assume growing Free Cash Flow that reaches well into the hundreds of millions of dollars over the next decade as the business scales.
Those rising cash projections mean the DCF output indicates an intrinsic value substantially above the current $108.66 share price. The recent cybersecurity data breach and related investigations help explain why the market still prices in a meaningful risk discount to those implied cash flows, even as Zio demand and management guidance feed into higher long term Free Cash Flow assumptions in the model. Find out what iRhythm Holdings could be worth using our Discounted Cash Flow (DCF) estimate.
The iRhythm Holdings Narrative: What Would Justify Today’s Price?
Simply Wall St Narratives for iRhythm Holdings pick up where the valuation puzzle leaves off. They spell out what would need to happen to iRhythm Holdings’ growth, margins and earnings for the stock to be worth materially more or less than today. These narratives sit on Simply Wall St’s Community page as a way to turn a single output from a ratio or model into a set of forward-looking assumptions you can monitor over time.
One of the top community narratives on iRhythm Holdings: 28% undervalued
“For you as an investor, the message is clear. The core story around iRhythm and VitalConnect is intact in most research, but valuation support now depends more heavily on successful integration…”
Discover why this Narrative puts iRhythm Holdings at 28% undervalued.
The iRhythm Holdings price is only one signal, the people steering it are the other
Before you stop at the cash flow story, look at who is steering iRhythm Holdings and how their incentives are structured, because that alignment can heavily influence what happens next. See who runs iRhythm Holdings and how they are paid.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include IRTC.
